ATMP at Royan Institute for Stem Cell Biology and Technology was established in 2018. A group of young scientists mainly “our faculty” members as well as our trained researchers work together to produce GMP grade “Stem Cell Products”. This newly established center aims to produce cell products in large-scale and clinical-grade quality to be used for “cell therapy” all over our country and other countries’ health systems.